Continuous Enrollment

KFF released a new report that shares a range of strategies states are using as they prepare to resume Medicaid disenrollment. The twenty-first annual KFF survey of state Medicaid Health Insurance (CHIP) Programs officials found that many states are using an array of strategies to promote continuity of coverage. The report shares findings from all states on their strategies to promote continuous coverage.

On March 15th, the Department of Health and Human Services, through CMS, announced 27 prescription drugs covered under Medicare Part B that may have lower beneficiary coinsurances. From April 1, 2023 through June 30, 2023, some people with Medicare who take these drugs may save between $2 and $390 per average dose, depending on the beneficiary’s coverage. Under the Inflation Reduction Act, signed into law in August 2022, drug companies that raise their drug prices faster than the rate of information are required to pay a rebate to Medicare. Starting April 1, 2023, Medicare beneficiaries may pay a lower coinsurance for certain Part B drugs if the drug’s price increased faster than the rate of inflation in a benchmark quarter.